Blockade of B7-H1 suppresses the development of chronic intestinal inflammation

Journal of Immunology

Volumn 171, Issue 8, 2003, Pages 4156-4163

  Kanai, Takanori ^a   Totsuka, Teruji ^a   Uraushihara, Koji ^a   Makita, Shin ^a   Nakamura, Tetsuya ^a   Koganei, Kazutaka ^b   Fukushima, Tsuneo ^b   Akiba, Hisaya ^c   Yagita, Hideo ^c   Okumura, Ko ^c   Machida, Utako ^a   Iwai, Hideyuki ^a   Azuma, Miyuki ^a   Chen, Lieping ^d   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; B7 H1 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RB HIGH ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIGAND; PROGRAMMED DEATH 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; COLITIS; COLON; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DENDRITIC CELL; ENTERITIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; INFLAMMATION; INTESTINE MUCOSA; LAMINA PROPRIA; LEUKOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; ULCERATIVE COLITIS; WASTING SYNDROME;

EID: 0141889125     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.8.4156     Document Type: Article

References (45)

1. Podolsky, D. K. 1995. Inflammatory bowel disease (first of two). N. Engl. J. Med. 325:928.
2. Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182.
3. Strober, W., and M. F. Neurath. 1996. Immunological diseases of the gastrointestinal tract. In Clinical Immunology. R. R. Rich, ed. Mosby, St. Louis, p. 1401.
4. MacDonald, T. T., and G. Monteleone. 2001. IL-12 and Th1 immune responses in human Peyer's patches. Trends Immunol. 22:244.
5. Schreiber, S. 2000. Inflammatory bowel disease: immunologic concepts. Hepato-Gastroenterology 47:15.
6. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-γ whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157:1261.
7. Kanai, T., M. Watanabe, A. Okazawa, K. Nakamaru, M. Okamoto, M. Naganuma, H. Ishii, M. Ikeda, M. Kurimoto, and T. Hibi. 2000. Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 119:1514.
8. Blumberg, R. S., L. J. Saubermann, and W. Strober. 1999. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immune 11:648.
9. Sartor, R. B. 1992. Role of the intestinal microflora in pathogenesis and complications. In Inflammatory Bowel Diseases: Pathophysiology as Basis of Treatment. J. H. Scolmerich, W. Goebell. W. Kruis, and W. Hohenberger. eds. Kluwer Academic. London, p. 175.
10. MacDonald, T. T., G. Monteleone, and L. F. Pender. 2000. Recent developments in the immunology of inflammatory bowel disease. Scand. J. Immunol. 51:2.
11. Bretscher, P. A., and M. Cohn. 1970. A theory of self and non-self discrimination. Science 169:1042.
12. Lenschow, D. J., G. S. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
13. + T cells. Immunol. Rev. 165:231.
14. Coyle, A. J., and J. C. Gutierrez-Ramos. 2001. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2:203.
15. Linsley, P. S., E. A. Clark, and J. A. Ledbetter. 1990. T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87:5031.
16. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Pillips, L. L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
17. Thompson, C. B., and J. P. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445.
18. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluèstone, and A. H. Sharp. 1995. Loss of CTLA-4 leads massive lymphoproliferation and fetal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
19. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985.
20. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
21. Luhder, F., P. Hoglund, J. P. Allison, C. Benoist, and D. Mathis. 1998. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187:427.
22. Ishida, Y., Agata, Y., Shibahara, K. and T. Honjo. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11:3887.
23. Nishimura, H., and T. Honjo. 2001. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22:265.
24. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11:141.
25. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116.
26. Agata, Y. A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita, and T. Honjo. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8:765.
27. Nishimura, H., T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, et al. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291:319.
28. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365.
29. Tseng, S. Y., M. Otsuji, K. Gorski, X. Huang, J. E. Slansky, S. I. Pai, A. Shalabi, T. Shin, D. M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193:839.
30. Freeman, G. J., Y. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027.
31. Latchman, Y., C. R. Wood, T. Chenova, D. Chaudhary, M. Borde, I. Chemova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261.
32. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169:5538.
33. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8:793.
34. Tamura, H., H. Dong, G. Zhu, G. L. Sica, D. B. Flies, K. Tamada, and L. Chen. 2001. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97:1809.
35. Dong, H., S. E. Strome, E. L. Matteson, K. G. Moder, D. B. Flies, G. Zhu, H. Tamura, C. L. W. Driscoll, and L. Chen. 2003. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 111:363.
36. Nyuyen, L. T., S. Radhakrishnan, B. Ciric, K. Tamada, T. Shin, D. M. Pardoll, L. Chen, M. Rodriguez, and L. R. Pease. 2002. Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells. J. Exp. Med. 196:1393.
37. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic role. Immunity 3:171.
38. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, et alH. Auchincloss, Jr., and M. H. Sayegh. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:63.
39. Salama, A. D., T. Chitnis, J. Imitola, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198:71.
40. Kanai, T., M. Watanabe, A. Okazawa, T. Sato, M. Yamazaki, S. Okamoto, H. Ishii, T. Totsuka, R. Iiyama, R. Okamoto, et al 2001. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 121:875.
41. Totsuka, T., T. Kanai, R. Iiyama, K. Uraushihara, M. Yamazaki, R. Okamoto, T. Hibi, K. Tezuka, M. Azuma, H. Akiba, et al. 2003. Ameliorating effect of anti-ICOS monoclonal antibody in a murine model of chronic colitis. Gastroenterology 124:410.
42. Iwai, Y., S. Terawaki, M. Ikegami, T. Okazaki, and T. Honjo. 2003. PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198:39.
43. Howie, D., M. Simarro, J. Sayos, M. Guirado, J. Sancho, and C. Terhorst. 2002. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation. Blood 99:957.
44. Wang, S., J. Bajorath, D. B. Flies, H. Dong, T. Honjo, and L. Chen. 2003. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197:1083.
45. + T cells independent of PD-1 receptor. J. Exp. Med. 198:31.